Large Scale Biology Corporation and Planet Biotechnology Inc., Announce Biomanufacturing Agreement 07/15/2004 -- Large Scale Biology Corporation (NASDAQ: LSBC) and privately held Planet Biotechnology Inc., (Planet) of Hayward, California, today announced initiation of a biomanufacturing agreement to extract and purify Planet's lead product, CaroRxT, a plant-made antibody to control dental caries.
Planet's CaroRxT is the world's first recombinant plant-made antibody to be clinically tested, and has been shown to prevent the adhesion of tooth decay causing bacteria to the tooth surface. Planet's tobacco plants expressing CaroRxT secretory IgA will be extracted by LSBC at its Owensboro, Kentucky, manufacturing facility. CaroRxT has completed Phase I clinical trials under an approved U.S. FDA Investigational New Drug (IND) application. "The experience and manufacturing capabilities that LSBC offers in the area of plant-produced recombinant protein extraction complements our proprietary gene expression and product development technologies," stated Elliott Fineman, President and CEO of Planet Biotechnology. "Larger quantities of CaroRxT are needed for our expanded clinical trials, and testing of formulations for the European market. We are happy to be working with LSBC during the scale-up phase of product development," Mr. Fineman added. "We are pleased to be working with Planet, a true pioneer in the development of plant-produced antibodies, as they expand their development program for their exciting new product, CaroRxT," said Kevin Ryan, LSBC's President and CEO. "Our new agreement with Planet further exemplifies LSBC's leadership role in the manufacture of plant-made pharmaceuticals and demonstrates the versatility of our Owensboro manufacturing facility in the extraction of a wide range of products," Mr. Ryan added. About Large Scale Biology Corporation Large Scale Biology uses its proprietary gene expression, molecular engineering and bioprocessing technologies to develop and manufacture therapeutic and industrial proteins, vaccines and diagnostic products for effective characterization and treatment of disease. Corporate offices, R&D laboratories and Eclipse Diagnostics Inc. are headquartered in Vacaville, California, and the Company's commercial-scale biomanufacturing facility is located in Owensboro, Kentucky. For more information about Large Scale Biology Corporation, visit the Company's website at www.lsbc.com. About Planet Biotechnology, Inc. Planet Biotechnology, Inc. is a privately held, clinical-stage company whose mission is to discover, develop and commercialize new monoclonal-antibody-based therapeutic and preventative products to meet significantly underserved medical needs. The Company's unique plant- derived antibody-based products ("plantibodies") have been produced through cultivation of genetically modified tobacco. Planet's headquarters and product development laboratories are located in Hayward, California. For additional information on Planet Biotechnology Inc. please visit the Company's website at www.planetbiotechnology.com. This release contains forward-looking statements about applications of LSBC's technologies and potential markets for product of one of our collaborators. These forward-looking statements involve risks, uncertainties and situations that may cause our actual results to differ materially from those implied by these statements, including our ability to commercialize one of our products, the ability of our collaborators to sell products we extract or make for them, the effectiveness of our and our collaborators' technologies to produce specific products and/or in a cost-effective manner, any difficulties or delays in obtaining regulatory approval to test and market such products, and the requirement of substantial funding for us to preserve our technology base and product pipeline. We cannot guarantee future results. You should not place undue reliance on these forward- looking statements, which apply only as of the date of this release. For a further list and description of such risks and uncertainties see the reports filed by Large Scale Biology Corporation with the Securities and Exchange Commission, including our reports on Forms 10-K and 10-Q. Except as required by law, we do not undertake to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. LSBCT, our logo and GENEWAREŽ are trademarks of Large Scale Biology Corporation. Planet and CaroRx are trademarks of Planet Biotechnology, Inc. ------------------------ Yahoo! Groups Sponsor --------------------~--> Has someone you know been affected by illness or disease? Network for Good is THE place to support health awareness efforts! http://us.click.yahoo.com/RzSHvD/UOnJAA/79vVAA/H4xqlB/TM --------------------------------------------------------------------~-> http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/">Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/">Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/">Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/">Arizona High Tech</a> Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/